Word: gardasil
(lookup in dictionary)
(lookup stats)
Dates: during 2000-2009
Sort By: most recent first
(reverse)
Last year, many students left school dismayed that the price of the HPV vaccine Gardasil, which remained at the prohibitive cost of $154 per shot at Harvard University Health Services (UHS). We sure did. Last fall, the Harvard HPV Vaccine Awareness Campaign collected over 900 signatures in support of a Harvard-sponsored subsidy for the vaccine to make it more accessible to female students. After meeting with UHS officials, we felt certain that the doctors were committed to student health; yet, we feared that bureaucratic challenges within the Harvard institution would keep us from realizing the goal...
...Imagine our delight when we returned to campus this fall to learn that UHS is offering Gardasil for $25 per shot for students with Harvard health insurance! We feel that this time UHS has truly listened to the needs of the students and acted swiftly to make this technology available to the campus. This step forward comes at a time when such a vaccine could truly make a positive public health difference here at Harvard...
...Whether you become sexually active during college or not is ultimately your personal decision, but the recent changes in the availability and affordability of Gardasil at UHS are a step in the right direction for improving options for both the sexually active and non-active members of our community. While we encourage all students to take advantage of the new lower-cost vaccine this year, make your sexual health a priority. Do the research and find out if it is right...
...shot. Women under the age of 26 on Harvard’s insurance plan will be able to obtain the vaccine, which has been shown to decrease risk of cervical cancer, at the new price from 10:00 a.m. to 4:00 p.m. today at a “Gardasil Clinic” in the Holyoke Center. The price drop comes after the Harvard College Women’s Center, the Seneca, and 13 other organizations led a campaign last year to publicize the benefits of the HPV vaccine in an attempt to pressure UHS into subsidizing the cost...
...only just begun on the safety of the vaccine in women older than 26. And, according to GlaxoSmithKline spokeswoman Liad Diamond, studying Cervarix in boys and men is "on the radar screen of the clinical development team" but there is "nothing underway right now." At Merck, clinical trials of Gardasil in males have been ongoing for about a year, and preliminary results show that "immune responses in 9- to 15-year-old boys are consistent with those found in females aged 16 to 23," according to Merck's Kelley Dougherty. Once efficacy data are available, Merck expects to submit applications...